Maintenance chemotherapy for non-small-cell lung cancer.
スポンサーリンク
概要
- 論文の詳細を見る
Currently, platinum-based combination chemotherapy is the standard first-line chemotherapy for non-small-cell lung cancer (NSCLC). Historically, platinum-based chemotherapy has been recommended for up to six cycles even for responders, and second-line chemotherapy has been considered when disease progression is confirmed. In spite of extensive investigations into maintenance chemotherapy, no positive data have been obtained; however, the results of recent clinical trials suggest both the safety and efficacy of maintenance chemotherapy in patients with NSCLC, although it is still controversial. In this review, we summarize the major clinical trials of maintenance chemotherapy in patients with NSCLC, and discuss its clinical validity and present future perspectives.
論文 | ランダム
- 持続的な施設野菜生産に不可欠な害虫の物理的防除技術
- 落ち着いて自発的に次の学習に取りかかることを目標とした自立活動の指導--他害行動を起こしやすい小学部男児への実践から
- 宅地開発公団,日本住宅公団(宅地部門)の51年度事業計画の概要
- 催青および上蔟後の温度が黒蛹の発現に及ぼす影響
- 支146号に見出された黒蛹の系統選抜と実用形質